PATENT CLAIM ANALYSIS

Application Number: 15939231
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["435", "220000"]

Abstract:
The present invention relates to the fields of collagenase production and collagenase products, and particularly to improving the reproducibility, purity, and stability of collagenase I and collagenase II compositions, where the compositions are pure to at least 95% by area as measured by reverse phase high pressure liquid chromatography (RP-HPLC) and essentially free of neutral protease.

Claim (Index 7):
The drug product of  claim 1  wherein the collagenase is at least one of collagenase I and collagenase II.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 90.0
- Lexical Diversity: 1.3913
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12474488', '13515203', '11699302', '13422939', '14394481']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.657093434104709
- 35 USC 102 Novelty (BERT): 0.5225423310433158
- Combined Prediction Score: 0.6436383237985697
- Mean Citation Score: 300.109898
- Max Citation Score: 338.7013
- Similarity Product: 251.63759328054192

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test